![A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer | SpringerLink A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00216-023-04569-y/MediaObjects/216_2023_4569_Figa_HTML.png)
A label-free dual immunosensor for the simultaneous electrochemical determination of CA125 and HE4 biomarkers for the early diagnosis of ovarian cancer | SpringerLink
![Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download](https://slideplayer.com/slide/6626598/23/images/4/Questions+Is+HE4+a+specific+tumor+marker.jpg)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
![Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1746-1596-8-11/MediaObjects/13000_2012_Article_730_Fig1_HTML.jpg)
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text
![HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6606092/MediaObjects/41416_2011_Article_BF6606092_Fig1_HTML.jpg)
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm | British Journal of Cancer
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2487ea26-1e5f-4b40-9ecd-fddbb803589d/ntbl003.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1e28ef43-c740-4fed-8a87-890cd2491360/ntbl004.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f50dc44db73d02a0fdaecab49c845d96479f6e8f/3-Table1-1.png)
PDF] Determination of the Reference Values of the Tumor Marker HE4 in Female Population of Canton Sarajevo | Semantic Scholar
![China manufacture supply ovarian cancer marker HE4 mAb Antibody - China Human Epididymis Protein 4, CA125 | Made-in-China.com China manufacture supply ovarian cancer marker HE4 mAb Antibody - China Human Epididymis Protein 4, CA125 | Made-in-China.com](https://image.made-in-china.com/202f0j00dogbrOcsLDqp/China-manufacture-supply-ovarian-cancer-marker-HE4-mAb-Antibody.jpg)
China manufacture supply ovarian cancer marker HE4 mAb Antibody - China Human Epididymis Protein 4, CA125 | Made-in-China.com
![Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma](https://pub.mdpi-res.com/sensors/sensors-21-03567/article_deploy/html/images/sensors-21-03567-ag.png?1626330784)
Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma
![Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry](https://pubs.acs.org/cms/10.1021/acs.analchem.3c00273/asset/images/medium/ac3c00273_0008.gif)
Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry
![A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//18075932/0000006700000005/v1_202212011555/S1807593222018178/v1_202212011555/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNfuNpdT3pEXC7tmqfbE1Y0Z1p9+vAlVDCDNpqpxHzzp8Z0ILrOhT7YePrkmPFgJXhRefw4ABU3JKFsav571eCDEBUhjI79Bed2vwyg+06u15e5p0zEc7NR8pKOODemQ8Jl7shbpnR5Z7fS6msjciMc9exfReX6xEt3CpsUcLrQq2+COvxzN0YvO0v9diCVzdtXH5DjBo0uguSf7DejoHnqvOJgN9DgkVeQr5ZRPIsThWOr2uAw3C2JxlJ7ad8KbJ5A=)
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics
![Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola, Prognostic and predictive value of combined HE-4 and CA-125 biomarkers during chemotherapy in patients with epithelial ovarian cancer - Enrico Potenza, Giulia Parpinel, Maria E. Laudani, Chiara Macchi, Luca Fuso, Paolo Zola,](https://journals.sagepub.com/cms/10.1177/1724600820955195/asset/images/large/10.1177_1724600820955195-fig2.jpeg)